Assessment of cell and gene therapy sponsor interactions with cber?s office of tissues and advanced therapies (otat)
Ended Awarded Last action
- Contract number
- 75F40121F19009
- Awardee
-
Guidehouse LLP UEI JG1JX6NL39U7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $5,925,000
Award facts
- Contract value 100% obligated
- $5,925,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,625,100 | |
| Original award | $3,299,900 |
About this award
This is a firm fixed-price BPA Call contract awarded by the Food and Drug Administration (FDA) to Guidehouse LLP, doing business as PricewaterhouseCoopers Public Sector, for the assessment of cell and gene therapy sponsor interactions with the FDA's Office of Tissues and Advanced Therapies (OTAT). The contract has a ceiling value of $5,925,000.00 and a completion date of July 5, 2022. This contract was awarded under the Multiple Award Schedule (MAS) contract vehicle. The contract does not have a set-aside designation.
Guidehouse is a global professional services firm that provides a wide range of management, technology, and risk consulting services to federal government agencies. The company has been awarded numerous prime and subcontract federal awards across multiple agencies, including significant Indefinite Delivery Vehicles (IDVs) with the Air Force Materiel Command, the U.S. Agency for International Development, the Department of Homeland Security, and NASA. Guidehouse also holds federal grant subawards, primarily through the National Center for Manufacturing Sciences, to support Department of Defense initiatives in areas like military sustainment, maintenance, and infrastructure.
Quick answers
Who was awarded contract 75F40121F19009?
75F40121F19009 was awarded to Guidehouse LLP by Food and Drug Administration (Department of Health and Human Services) on February 18, 2021.
How much is contract 75F40121F19009 worth?
The government has obligated $5,925,000 on 75F40121F19009.
Is contract 75F40121F19009 an order under another contract?
Yes. 75F40121F19009 is a BPA call under GS35F0263P-75F40119A10017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19009 competed?
The extent of competition for 75F40121F19009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award